World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Twist Bioscience Corporation

    World Rank (Jan-05-2024)
    5,792
    Market Cap (Jan-05-2024)
    1.936 Billion USD
    World Rank (Jul-30-2023)
    7,096
    Market Cap (Jul-30-2023)
    1.428 Billion USD
    World Rank (Dec-25-2022)
    7,146
    Market Cap (Dec-25-2022)
    1.312 Billion USD
    World Rank (Jan-07-2022)
    4,437
    Market Cap (Jan-07-2022)
    3.39 Billion USD
    Annual Revenue in USD
    203 Million USD
    Annual Operating Income in USD
    -249 Million USD
    Annual Net Income in USD
    -217 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    USA
    Yahoo @ MunichGermany
    Company Profile
    TWIST BIOSCIENCE CORPORATION is Biotechnology company and has created silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to their customers.
    • Innovative silicon-based DNA Synthesis Platform enables production of high-quality synthetic DNA faster and more affordable than ever before
    • Platform technology overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis.

    Headquarters is in USA.

    Company Website
    TWIST BIOSCIENCE CORPORATION
    Wikipedia
    Wikipedia

  2. Da An Gene of Sun Yat-Sen University

    World Rank (Jan-05-2024)
    5,862
    Market Cap (Jan-05-2024)
    1.904 Billion USD
    World Rank (Jul-30-2023)
    5,778
    Market Cap (Jul-30-2023)
    1.981 Billion USD
    World Rank (Dec-25-2022)
    3,853
    Market Cap (Dec-25-2022)
    3.266 Billion USD
    World Rank (Jan-07-2022)
    3,530
    Market Cap (Jan-07-2022)
    4.56 Billion USD
    Annual Revenue in USD
    1,115 Million USD
    Annual Net Income in USD
    526 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Profile
    Da An Gene of Sun Yat-sen University is a biomedical high-tech enterprise which is led by molecular diagnostic technology and integrates the research and development, production and sales of clinical test reagents and instruments as well as the clinical test service of national chain independent medical laboratories company. It has 54 products were identified as high tech products in Guangdong province which provides a powerful guarantee for products entering the domestic and international market. The headquarters is in China.
    Company Website
    DA AN GENE OF SUN YAT-SEN UNIVERSITY

  3. Veracyte

    World Rank (Jan-05-2024)
    5,873
    Market Cap (Jan-05-2024)
    1.898 Billion USD
    World Rank (Jul-30-2023)
    5,673
    Market Cap (Jul-30-2023)
    2.035 Billion USD
    World Rank (Dec-25-2022)
    5,892
    Market Cap (Dec-25-2022)
    1.764 Billion USD
    World Rank (Jan-07-2022)
    5,608
    Market Cap (Jan-07-2022)
    2.39 Billion USD
    Annual Revenue in USD
    296 Million USD
    Annual Operating Income in USD
    -41 Million USD
    Annual Net Income in USD
    -37 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Veracyte is a Pioneering Genomic Diagnostics company. It's innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis. The headquarters is in USA.
    Company Website
    VERACYTE INC

  4. Summit Therapeutics

    World Rank (Jan-05-2024)
    5,892
    Market Cap (Jan-05-2024)
    1.889 Billion USD
    World Rank (Jul-30-2023)
    6,946
    Market Cap (Jul-30-2023)
    1.479 Billion USD
    World Rank (Dec-25-2022)
    15,677
    Market Cap (Dec-25-2022)
    0.302 Billion USD
    World Rank (Jan-07-2022)
    17,453
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -64 Million USD
    Annual Net Income in USD
    -79 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SUMMIT THERAPEUTICS

  5. Liaoning Chengda Biotechnology Co. Ltd

    World Rank (Jan-05-2024)
    5,919
    Market Cap (Jan-05-2024)
    1.875 Billion USD
    World Rank (Jul-30-2023)
    5,793
    Market Cap (Jul-30-2023)
    1.975 Billion USD
    World Rank (Dec-25-2022)
    5,779
    Market Cap (Dec-25-2022)
    1.815 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Profile

    It is a biotechnology company that develop vaccines. Headquarters is in China.

  6. Harmony Biosciences Holdings Inc.

    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    437 Million USD
    Annual Operating Income in USD
    120 Million USD
    Annual Net Income in USD
    181 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

  7. Viking Therapeutics

    World Rank (Jan-05-2024)
    5,954
    Market Cap (Jan-05-2024)
    1.859 Billion USD
    World Rank (Jul-30-2023)
    7,050
    Market Cap (Jul-30-2023)
    1.442 Billion USD
    World Rank (Dec-25-2022)
    10,811
    Market Cap (Dec-25-2022)
    0.648 Billion USD
    World Rank (Jan-07-2022)
    16,059
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -70 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Viking Therapeutics is a Clinical Stage Biopharmaceutical company. It is focused on the development of novel, orally available, first in class or best in class therapies for the treatment of metabolic and endocrine disorders. The company annual revenue is 7.3 million USD and 15 employees as 2019. The headquarters is in USA.
    Company Website
    VIKING THERAPEUTICS

  9. Porton Pharma Solutions

    World Rank (Jan-05-2024)
    5,987
    Market Cap (Jan-05-2024)
    1.840 Billion USD
    World Rank (Jul-30-2023)
    5,451
    Market Cap (Jul-30-2023)
    2.176 Billion USD
    World Rank (Dec-25-2022)
    4,070
    Market Cap (Dec-25-2022)
    3.007 Billion USD
    World Rank (Jan-07-2022)
    2,779
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    487 Million USD
    Annual Net Income in USD
    82 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    PORTON PHARMA SOLUTIONS

  10. Bellus Health

    World Rank (Jan-05-2024)
    5,990
    World Rank (Jul-30-2023)
    5,990
    Market Cap (Jul-30-2023)
    1.870 Billion USD
    World Rank (Dec-25-2022)
    7,834
    Market Cap (Dec-25-2022)
    1.121 Billion USD
    World Rank (Jan-07-2022)
    11,402
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Headquarters Country
    Canada
    Company Profile

    BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.

    Company Website
    BELLUS HEALTH

Share